WOODMONT INVESTMENT COUNSEL LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 151 filers reported holding GW PHARMACEUTICALS PLC in Q3 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
WOODMONT INVESTMENT COUNSEL LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2017$203,000
+1.0%
2,0000.0%0.06%
-3.5%
Q2 2017$201,000
+1446.2%
2,000
+1900.0%
0.06%
+1325.0%
Q3 2016$13,000
-7.1%
100
-50.0%
0.00%0.0%
Q1 2016$14,0000.0%2000.0%0.00%0.0%
Q4 2015$14,000
-22.2%
2000.0%0.00%
-20.0%
Q3 2015$18,000
-25.0%
2000.0%0.01%
+25.0%
Q2 2015$24,0002000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2016
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders